Target Name: PIGZ
NCBI ID: G80235
Review Report on PIGZ Target / Biomarker Content of Review Report on PIGZ Target / Biomarker
PIGZ
Other Name(s): GPI mannosyltransferase IV | PIGZ_HUMAN | GPI-MT-IV | Phosphatidylinositol-glycan biosynthesis class Z protein | Dol-P-Man dependent GPI mannosyltransferase | phosphatidylinositol glycan anchor biosynthesis class Z | Phosphatidylinositol glycan, class Z | SMP3 mannosyltransferase | dol-P-Man dependent GPI mannosyltransferase | hSMP3 | phosphatidylinositol-glycan biosynthesis class Z protein | SMP3 homolog | GPI mannosyltransferase 4 | SMP3 | PIG-Z | phosphatidylinositol glycan, class Z | Phosphatidylinositol glycan anchor biosynthesis class Z

Understanding PIGZ: A Potential Drug Target and Biomarker

PIGZ (phosphoglycerate kinase-related subfamily 4) is a protein that is expressed in various tissues and cells in the human body. It is a member of the GPI (glycophosphatidylinositol) signaling pathway, which is a well-established signaling pathway that involves the interaction between various signaling molecules. PIGZ is involved in the regulation of various cellular processes, including cell signaling, cell adhesion, and cell survival.

The GPI signaling pathway is a critical pathway that involves the interaction between various signaling molecules, including G-protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play a critical role in cellular signaling. GPCRs are involved in the regulation of various cellular processes, including sensory perception, neurotransmission, and hormone signaling.

PIGZ is a key enzyme involved in the regulation of GPCRs. It is a potent GPCR activator, which means that it can activate GPCRs to transmit signals from various signaling molecules to the cell. PIGZ is involved in the regulation of many different signaling pathways, including the regulation of cell proliferation, differentiation, and survival.

One of the key challenges in the study of PIGZ is its complex structure. PIGZ is a 12-kDa protein that consists of four transmembrane domains and a cytoplasmic tail. It has a unique fold structure that is intermediate between that of GPCRs and other proteins.

PIGZ is involved in the regulation of various cellular processes, including cell signaling, cell adhesion, and cell survival. It is a potent GPCR activator, which means that it can activate GPCRs to transmit signals from various signaling molecules to the cell. PIGZ is involved in the regulation of many different signaling pathways, including the regulation of cell proliferation, differentiation, and survival.

PIGZ is a potential drug target and biomarker. Its unique structure and involvement in various cellular processes make it an attractive target for drug development. Additionally, its involvement in the regulation of GPCRs makes it a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

Conclusion

In conclusion, PIGZ is a protein that is involved in the regulation of various cellular processes, including cell signaling, cell adhesion, and cell survival. It is a potent GPCR activator and a potential drug target and biomarker. Further research is needed to fully understand its role in the regulation of cellular processes and its potential as a drug target and biomarker.

Protein Name: Phosphatidylinositol Glycan Anchor Biosynthesis Class Z

Functions: Mannosyltransferase involved in glycosylphosphatidylinositol-anchor biosynthesis. Transfers a fourth mannose to some trimannosyl-GPIs during GPI precursor assembly. The presence of a fourth mannose in GPI is facultative and only scarcely detected, suggesting that it only exists in some tissues

The "PIGZ Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIGZ comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PIH1D1 | PIH1D2 | PIK3AP1 | PIK3C2A | PIK3C2B | PIK3C2G | PIK3C3 | PIK3CA | PIK3CA-DT | PIK3CB | PIK3CD | PIK3CD-AS1 | PIK3CD-AS2 | PIK3CG | PIK3IP1 | PIK3IP1-DT | PIK3R1 | PIK3R2 | PIK3R3 | PIK3R4 | PIK3R5 | PIK3R6 | PIKFYVE | PILRA | PILRB | Pim Kinase | PIM1 | PIM2 | PIM3 | PIMREG | PIN1 | PIN1-DT | PIN1P1 | PIN4 | PINCR | PINK1 | PINK1-AS | PINLYP | PINX1 | PIP | PIP4K2A | PIP4K2B | PIP4K2C | PIP4P1 | PIP4P2 | PIP5K1A | PIP5K1B | PIP5K1C | PIP5K1P1 | PIP5KL1 | PIPOX | PIPSL | PIR | PIR-FIGF | PIRAT1 | PIRT | PISD | PISRT1 | PITHD1 | PITPNA | PITPNA-AS1 | PITPNB | PITPNC1 | PITPNM1 | PITPNM2 | PITPNM2-AS1 | PITPNM3 | PITRM1 | PITRM1-AS1 | PITX1 | PITX1-AS1 | PITX2 | PITX3 | PIWIL1 | PIWIL2 | PIWIL2-DT | PIWIL3 | PIWIL4 | PIWIL4-AS1 | PJA1 | PJA2 | PJVK | PKD1 | PKD1-AS1 | PKD1L1 | PKD1L1-AS1 | PKD1L2 | PKD1L3 | PKD1P1 | PKD1P4-NPIPA8 | PKD1P6 | PKD2 | PKD2L1 | PKD2L2 | PKD2L2-DT | PKDCC | PKDREJ | PKHD1 | PKHD1L1 | PKIA